Eiko Lifesciences Share Price
17 Nov, 2026 12:57 PM (IST)
Eiko Lifesciences Performance
- Today's Low
- ₹49
- Today's High
- ₹52
- 52 Week Low
- ₹43
- 52 Week High
- ₹59
- Open Price₹52
- Previous Close₹51
- Volume453
- 50 DMA₹49.30
- 100 DMA₹49.30
- 200 DMA₹50.00
Eiko Lifesciences Chart
Investment Returns
- Over 1 Month + 4.08%
- Over 3 Month + 5.94%
- Over 6 Month + 3.32%
- Over 1 Year -6.85%
Smart Investing Starts Here Start SIP with Eiko Lifesciences for Steady Growth!
Eiko Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 13.5
- PEG Ratio
- 0.3
- Market Cap Cr
- 70
- P/B Ratio
- 1
- Average True Range
- 2.6
- EPS
- 3.8
- Dividend Yield
- 0
- MACD Signal
- 0.3
- RSI
- 53.46
- MFI
- 60.59
Latest Stock News Updates
In continuation to our earlier announcement dated 05th November, 2026. We wish to inform that the Wholly Owned Subsidiary of the Company namely 'Eiko Scientific Solutions LLP' (LLPIN: ACH-4311) has entered into a Joint Venture by forming a Private Limited Company in the name of 'Oval Eiko Resources Private Limited'. Oval Eiko Resources Private Limited is incorporated as a joint venture between Oval Projects Engineering Limited and Eiko Scientific Solutions LLP, with each holding 50% of share capital.
- BSE India
- 3 days 21 hours ago
Please find enclosed a copy of newspaper publication in the following newspapers dated 06th November, 2026 with respect to Unaudited Financial Results (Standalone & Consolidated) of the Company for the Quarter and Half-year ended 30th September, 2026 approved at the meeting of Board of Directors held on Thursday, 05th November, 2026. 1. Active Times (English) 2. Mumbai Lakshadeep (Marathi)
- BSE India
- 1 week 4 days ago
Wholly Owned Subsidiary of the Company namely 'Eiko Scientific Solutions LLP' (LLPIN: ACH-4311) is proposed to enter into a Joint Venture Agreement with Oval Projects Engineering Limited for formation of a new Private Limited Company in the name of Oval Eiko Resources Private Limited. The private limited company will be incorporated as a joint venture between Oval Projects Engineering Limited and Eiko Scientific Solutions LLP, with each holding 50% of share capital.
- BSE India
- 1 week 4 days ago
Eiko Lifesciences Financials
Eiko Lifesciences Technicals
EMA & SMA
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹49.90
- 50 Day
- ₹49.30
- 100 Day
- ₹49.30
- 200 Day
- ₹50.00
Resistance and Support
- R3 54.70
- R2 53.00
- R1 51.90
- S1 49.00
- S2 47.40
- S3 46.20
Eiko Lifesciences Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-11-05 | Quarterly Results | |
| 2026-08-12 | Quarterly Results | |
| 2026-05-26 | Audited Results | |
| 2026-01-29 | Quarterly Results | |
| 2025-12-11 | Others | Inter alia, To consider the proposal for raising of funds by way of issue of one or more of instruments comprising of Equity Shares, Convertible Securities through Private Placement/Preferential Issue |
About Eiko Lifesciences
Eiko Lifesciences engaged in specialty chemicals and pharmaceutical intermediates sector, the Company is committed to conducting its business with the highest standards of integrity, ethical conduct, transparency and accountability. The governance framework of the Company is designed to ensure responsible decision-making, effective risk management, regulatory compliance and protection of stakeholder interests while fostering innovation, operational excellence and business sustainability. View More- NSE Symbol
- EIKO
- BSE Symbol
- 540204
- ISIN
- INE666Q01016
Similar Stocks to Eiko Lifesciences
Popular Stocks
Eiko Lifesciences FAQs
Eiko Lifesciences share price is ₹51 As on 17 November, 2026 | 13:04
The Market Cap of Eiko Lifesciences is ₹70 Cr As on 17 November, 2026 | 13:04
The P/E ratio of Eiko Lifesciences is 13.5 As on 17 November, 2026 | 13:04
The PB ratio of Eiko Lifesciences is 1 As on 17 November, 2026 | 13:04
The 52 week High & Low of Eiko Lifesciences is ₹59/₹43 respectively As on 17 November, 2026 | 13:04
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.